However, admission for arrhythmia (OR 0.5, p=0.045), ACE inhibitor/angiotensin II receptor blockers use (OR 0.35, p=0.006), digoxin use (OR 0.4, p=0.013) and high albumin (OR 0.9, p=0.019) predicted lower 1-year all-cause mortality. The gene discussed is ACE; the disease is Arrhythmia.